triamcinolone acetonide, moxifloxacin, and vancomycin

FDA: Risk of blindness from compounded eye drugFDA warns that this compounded eye drug could lead to a disease that causes blindness.
Transzonular intravitreal injection eases treatment burden after cataract surgery
Transzonular intravitreal injection eases treatment burden after cataract surgeryAn intraoperative injection of a compounded formulation of triamcinolone acetonide, moxifloxacin, and vancomycin eliminated the need for supplemental postoperative medications in the vast majority of patients who underwent phacoemulsification and IOL implantation.